BCL-2 inhibitor sensitizes the latent HIV reservoir to elimination by CTLs

• S.-H. Huang,
• Y. Ren,
• A. Macedo,
• S. Patel,
• D. Chan,
• E. Horch,
• R. Truong,
• C. Bollard,
• A. Bosque,
• R.B. Jones

Affiliations

S.-H. Huang

Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, DC, USA

Y. Ren

Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, DC, USA

A. Macedo

Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, DC, USA

S. Patel

Center for Cancer and Immunology Research, Children's National Health System, Washington, DC, USA

D. Chan

Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, DC, USA

E. Horch

Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, DC, USA

R. Truong

Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, DC, USA

C. Bollard

Center for Cancer and Immunology Research, Children's National Health System, Washington, DC, USA

A. Bosque

Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, DC, USA

R.B. Jones

Department of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, DC, USA